Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OLANZAPINE vs OLMESARTAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

OLANZAPINE vs OLMESARTAN: Safety Overview

Metric OLANZAPINE OLMESARTAN
Total FAERS Reports 51,444 2,228
Deaths Reported 5,535 77
Death Rate 10.8% 3.5%
Hospitalizations 21,934 1,096
Average Patient Age 44.3 yrs 68.9 yrs
% Female Patients 46.1% 52.8%
FDA Approval Date Apr 23, 2012 N/A
Manufacturer REMEDYREPACK INC. N/A
Route ORAL N/A
Marketing Status Prescription N/A